Dr Lim Zi Yi is the Medical Director of CFCH and a Senior Consultant in Haematology. He has a specialist interest in Haemato-oncology and Haematopoietic Stem Cell Transplantation. In addition, he has wide experience in the management of general haematological conditions (such as clotting disorders, anaemia, bleeding disorders). He received his medical degree from the University of Edinburgh, UK and subsequently underwent specialist training in haemato-oncology at Kings College Hospital, London where he helped to develop it into one of the largest allogeneic haematopoietic stem cell transplant centres in Europe. He subsequently returned to Singapore where he led the development of several haematological services in the public and private sector.

Dr Lim is passionate about approaching patient care in a holistic manner, utilising state of the art diagnostic tests together with novel treatment protocols to develop personalized treatment strategies for his patients.

Dr Lim is fluent in English and Mandarin.

Qualifications

• MBChB, University of Edinburgh
• Fellow of the Royal College of Pathologists, UK
• Fellow of the Royal College of Physicians (Edinburgh), UK
• Tito Bastianello Award for Best Young Investigator, 9th International Symposium on Myelodysplastic Syndromes, Italy, 2007
• Awarded the NUHS Clinician Scientist Program Award, 2012

Background

• Worked at King’s College Hospital, London for almost 10 years
• Experienced in various forms of allogeneic haematopoietic stem cell transplantation and has personally overseen the management of more than 350 bone marrow transplants since 2008
• Published more than 50 peer-reviewed papers on myeloid cancers and transplantation, many in high-impact journals such as Journal of Clinical Oncology, Blood, Leukemia and Haematologica
• Lead for adult leukaemia service at NUHS (2011-2013)
• Lead for adult haematopoietic stem cell transplant service at Parkway Cancer Centre (2013-2019)
• President of the Bone Marrow Donor Programme (BMDP) Singapore
• Co-Founder and CEO of the cellular therapy manufacturing start-up CellVec Pte Ltd
• Formed the Centre for Clinical Haematology 2019